Rahmati Jeiran, Ahmadi Saba, Rezaei Sepideh, Hosseinifard Hossein, Dehnad Afsaneh, Shabaninejad Hosein, Aryankhesal Aidin, Ghasemyani Shabnam, Alihosseini Samira, Mansour Kiaee Zahra, Noorani Mejareh Zahra, Aghalou Sepideh, Ghashghaee Ahmad, Shoghi Mahnaz, Ahmadi Nasab Mohammad, Khajehvand Anahita
Student Research Committee, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Med J Islam Repub Iran. 2021 Aug 9;35:101. doi: 10.47176/mjiri.35.101. eCollection 2021.
Anxiety affects social, economic, and physical aspects of daily life in patients with AIDS. Therefore, it is necessary to take preventive measures and design plans to maintain their general health. The present study was the first comprehensive systematic literature review research that examined the worldwide prevalence rate of anxiety in patients with AIDS. We searched for papers published in the English language in the major databases including Embase, PubMed, Web of Science, Scopus, Cochrane, and Google Scholar from 2000 to October 2018. There were 40 studies which found to be eligible. These studies were independently evaluated and the collected data were entered in a data extraction form, which was then analyzed by two authors and a third author if necessary. Der Simonian-Laird model was used to estimate the prevalence rate on a Forest plot at the interval confidence of 95%. The total sample size was 24111, and the total number of people with anxiety was 5546. The results based on the random-effects model showed that the rate of anxiety prevalence in the patients was 25% (CI: 95%, 21% -30%) with heterogeneity of 97.9% and a significance level of p<0.001. The South America continent with a prevalence of 38% (95% CI, 34%-42%) had the highest anxiety prevalence rates and Africa with 19% (95% CI, 12% -29%) had the lowest anxiety prevalence rates. Based on findings, the prevalence of anxiety in developed countries was partially higher than in underdeveloped countries and the obtained mean in the present study. It can be a significant point for policymakers. Therefore, WHO and the world community should have special plans for these countries.
焦虑会影响艾滋病患者日常生活的社会、经济和身体方面。因此，有必要采取预防措施并制定计划来维持他们的总体健康。本研究是第一项全面系统的文献综述研究，考察了全球艾滋病患者的焦虑患病率。我们在Embase、PubMed、Web of Science、Scopus、Cochrane和谷歌学术等主要数据库中搜索了2000年至2018年10月期间发表的英文论文。共筛选出40项符合条件的研究。这些研究由两位作者独立评估，收集的数据录入数据提取表，如有必要，第三位作者也会参与分析。采用Der Simonian-Laird模型在95%的区间置信度下估计森林图上的患病率。总样本量为24111，焦虑患者总数为5546。基于随机效应模型的结果显示，患者的焦虑患病率为25%（置信区间：95%，21%-30%），异质性为97.9%，显著性水平p<0.001。南美洲大陆的患病率最高，为38%（95%置信区间，34%-42%），非洲的患病率最低，为19%（95%置信区间，12%-29%）。基于研究结果，发达国家的焦虑患病率部分高于欠发达国家以及本研究得出的平均水平。这对政策制定者来说可能是一个重要问题。因此，世界卫生组织和国际社会应该为这些国家制定特别计划。
